Somatostatin Receptor Expressing Bilateral Ovarian Metastases Detected by 68Ga DOTANOC PET/CT. (June 2015)

• Record Type: Journal Article
• Authors: Arora, Saurabh; Soundararajan, Ramya; Joshi, Prashant; Kumar, Rakesh; Bal, Chandrasekhar
• Is Part Of: Clinical nuclear medicine. Volume 40:Number 6(2015)
• Publication Date: 2015-06
• Subjects: neuroendocrine tumor -- bilateral ovarian metastases -- 68Ga DOTANOC PET/CT; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000000646
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Abstract: Bilateral ovarian metastasis from neuroendocrine tumor (NET) is uncommon. Ovarian NET could be primary or metastatic, and if it is bilateral, then the chances of metastatic disease are from 88% to 94%. Proper identification and appropriate management become necessary in such patients. Somatostatin receptor imaging by 68 Ga-labeled DOTANOC ([1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid]-1-NaI3-Octreotide) PET/CT can be used for localization, staging, and restaging of NET, and it also has an impact on appropriate clinical management of patients with NET. We present here a case of somatostatin receptor expressing bilateral ovarian metastases from NET demonstrated by 68 Ga DOTANOC PET/CT imaging.